News and Press Releases
Exonate announces successful completion of phase 1b/2a trial in diabetic macular oedema
Lead ophthalmology candidate EXN407 has potential to be the first topical treatment for diabetic retinopathy/diabetic macular oedema EXN407 met all endpoints and displayed encouraging biological activity in diabetic patients with...
Category: Clinical Trials
Posted: November 28, 2023
Phastar Offers Pro Bono Support to Medicines Development for Global Health
Supporting medicine development for disadvantaged communities 26th October 2023 -- London, UK, and North Carolina, US -- Phastar, a global specialist biometrics contract research organisation (CRO), is offering pro bono support to...
Category: Other
Posted: October 30, 2023
Commercial study set up times reduced by a third, according to new data
26 October 2023 -- London, England -- New data from the National Institute for Health and Care Research (NIHR) shows that the National Contract Value Review has significantly reduced the...
Category: Clinical Trials
Posted: October 26, 2023
Results from Phase 2 THOR-2 Study Showed Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with Erdafitinib Versus Chemotherapy
Data from Cohort 1 of the phase 2 THOR-2 study showed oral erdafitinib reduced the risk of disease recurrence or death compared with intravesical standard-of-care chemotherapy 21 October 2023 --...
Category: Clinical Trials
Posted: October 23, 2023
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
AstraZeneca reinforces commitment to protecting the most vulnerable from serious infectious diseases at IDWeek 2023
Real-world data from INFORM study demonstrate increased risk of severe COVID-19 outcomes among all individuals with immunocompromising conditions and highlight need for additional protection FluMist Quadrivalent data support the potential...
Category: Clinical Trials
Posted: October 12, 2023
PLC 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA UK
Clinical Trials Specialist Panthera Biopartners Scoops Pharma Industry Award
11 October 2023 -- Preston, UK -- After only four years since it was founded, Panthera Biopartners has been crowned ‘Pharma Research Centre of the Year’ at the prestigious Pharma...
Category: Other
Posted: October 11, 2023
Phastar Net-Zero Target Approved by the Science Based Targets Initiative
Phastar commits to achieving Net-Zero Standard by 2035 4 October 2023 -- London, UK, and North Carolina, US -- Phastar, a global specialist biometrics contract research organisation (CRO), has had...
Category: Drug Discovery
Posted: October 6, 2023
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company’s Combination Vaccine Against Influenza and COVID-19
mRNA-1083 showed strong immunogenicity against influenza and COVID-19, with an acceptable reactogenicity and safety profile, compared to licensed standalone vaccines Company to begin phase 3 trial of mRNA-1083 in adults...
Category: Clinical Trials, Drug Discovery
Posted: October 4, 2023
Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical Development for Emerging Biopharmaceutical Organisations
3 October 2023 -- Philadelphia, US -- Signant Health, the leader in evidence generation for modern clinical trials, announced today the launch of Signant Biotech – an integrated clinical research...
Category: Clinical Trials
Posted: October 4, 2023
Shionogi Presents New Ensitrelvir Clinical and Real-World Data Reinforcing Potential Across COVID-19 Populations at ESWI 2023
New exploratory analysis of phase 3 SCORPIO-SR study data in Asia suggests that ensitrelvir may reduce the risk of persistent and new late-onset symptoms associated with long COVID-19 over one...
Category: Clinical Trials
Posted: September 20, 2023
Mural Health Raises $8m Led by Bessemer Venture Partners to Accelerate Growth
Funding enables Mural Health to expand its Mural Link platform to modernise the clinical trial participant experience 19 September 2023 -- Pennsylvania, US -- Mural Health Technologies, a next-generation clinical...
Category: Clinical Trials
Posted: September 20, 2023
Invitation to learn from the best: Evening of insights and networking will honour a clinical data management stalwart
Prof Deborah Ashby to give the 2023 Sally Hollis Memorial Lecture in Macclesfield 13 September 2023 -- London, UK and North Carolina, US -- A leading global expert on clinical...
Category: Clinical Trials
Posted: September 18, 2023
Phastar Appoints Graham Clark as New Chief Executive Officer
Phastar Sets Course for Further Growth with New CEO Appointment 10 August 2023 -- London, UK, and North Carolina, US -- Phastar, a global specialist biometrics contract research organisation (CRO),...
Category: Clinical Trials
Posted: August 17, 2023
